Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate for Chronic Central Serous Chorioretinopathy
NCT00489840Phase 2Completed
- Sponsor
- Manhattan Eye, Ear and Throat Hospital
- Start
- May 2007
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anecortave in Central Serous Chorioretinopathy (CSCR), sponsored by Manhattan Eye, Ear and Throat Hospital. Started May 2007; status: completed.
02
Drugs
anecortave
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT00489840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489840.